Skip to content

Clinical trials

Phase 2/3 Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2/3 Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20111
20171
20182
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Amgen1
Bristol-Myers Squibb1
British Columbia Cancer Agency1
Celgene1
McMaster University1
Milton S. Hershey Medical Center1
Pfizer1
The Hospital for Sick Children1
University of British Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms11
Acute Lung Injury1
Anorexia1
Cachexia1
Cancer Pain1
Carcinoma, Non-Small-Cell Lung1
Fatigue1
Inflammation1
Leukemia1
Lymphoma, B-Cell1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.